TrialCancer science2013

Immunotherapeutic benefit of α-interferon (IFNα) in survivin2B-derived peptide vaccination for advanced pancreatic cancer patients.

Hidekazu Kameshima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.